[EN] HYDROCARBYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER [FR] PYRIDINES À SUBSTITUTION HYDROCARBYLSULFONYLE ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER
[EN] HYDROCARBYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER [FR] PYRIDINES À SUBSTITUTION HYDROCARBYLSULFONYLE ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER
Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
申请人:Oblique Therapeutics AB
公开号:US11161815B2
公开(公告)日:2021-11-02
There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
提供了式 I (I)化合物或其药学上可接受的盐类,其中 L、R1、R2、R3 和 X 具有描述中提供的含义,这些化合物可用于治疗癌症。
HYDROCARBYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER
申请人:Oblique Therapeutics AB
公开号:US20200239417A1
公开(公告)日:2020-07-30
There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R
1
, R
2
, R
3
and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
[EN] HYDROCARBYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER<br/>[FR] PYRIDINES À SUBSTITUTION HYDROCARBYLSULFONYLE ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER
申请人:OBLIQUE THERAPEUTICS AB
公开号:WO2018146472A1
公开(公告)日:2018-08-16
There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.